Dipharma

Highly Engaged Employees

Dipharma, established in 1949, operates as a global Contract Development and Manufacturing Organization (CDMO) and Active Pharmaceutical Ingredient (API) manufacturer. The company excels in exclusive synthesis services and offers an extensive catalog of APIs tailored for the generic pharmaceutical market. Dipharma positions itself as a strategic partner, dedicated to alleviating the development and manufacturing complexities for its clients while consistently ensuring high-quality standards and pioneering innovative solutions. This focus on quality and innovation underpins its role in the pharmaceutical supply chain.

With an employee range of 500 - 1,000 individuals, Dipharma manages operations across four cGMP-compliant plants and commercial offices strategically located in Italy, the USA, and China, underscoring its significant global presence. This extensive network facilitates its capacity to serve a diverse international clientele. To gain insight into the personnel driving these critical functions, one can `Meet Dipharma's team`. The company's operational ethos is deeply rooted in a commitment to sustainability and rigorous quality assurance, enabling it to provide robust support to pharmaceutical industry partners worldwide.

Operating within the Pharmaceuticals and Healthcare industries, Dipharma's product portfolio encompasses pharmaceutical ingredients, active pharmaceutical ingredients (APIs), and specialized contract development services. The company navigates a competitive landscape, contending with entities such as Pliva, STA Pharmaceutical, and Cambrex, among others. Dipharma's core strengths lie in its high-quality API manufacturing capabilities and its expertise in exclusive synthesis, solidifying its reputation as a dependable provider of essential chemical and generic ingredient solutions for the global pharmaceutical sector.